Research has showed that increased serum IL-10 levels could facilitate development of tumors by suppressing the expression of MHC class I and II antigens [87] and preventing tumor antigen presentation to CD8-cytotic T lymphocytes. This evidence concerns the gene IL10 and neoplasm.